The GPT Healthcare IPO is scheduled to open for subscription on February 22, 2024, and will close on February 26, 2024. The IPO aims to raise approximately ₹525.14 crores, comprising a fresh issue of 0.22 crore shares amounting to ₹40.00 crores and an offer for sale of 2.61 crore shares totaling ₹485.14 crores. The price band for the IPO is set at ₹177 to ₹186 per share, with a minimum lot size of 80 shares. The minimum investment required for retail investors is ₹14,880, with specific investment brackets detailed for sNII and bNII categories.
The IPO’s allocation is divided among various investor categories, with not more than 50.00% of the net offer for Qualified Institutional Buyers (QIBs), not less than 35.00% for retail investors, and not less than 15.00% for Non-Institutional Investors (NIIs). The listing date is tentatively set for February 29, 2024, on both BSE and NSE.
GPT Healthcare operates a network of mid-sized, full-service hospitals in Eastern India, focusing on secondary and tertiary care. As of September 30, 2023, it manages four multispecialty hospitals located in Dum Dum, Salt Lake, Howrah (West Bengal), and Agartala (Tripura), collectively offering 561 beds. The company’s hospitals are recognized for their quality of medical services, holding accreditations from NABH and NABL, and certifications from international bodies like the Surgical Review Corporation, USA.
The IPO proceeds are intended for the repayment or prepayment of certain outstanding borrowings availed by the company from banks and financial institutions, as well as for general corporate purposes.
Investors interested in participating in the GPT Healthcare IPO can apply via ASBA available in their bank accounts or through IPO forms available for download on NSE and BSE websites. The company’s strategic focus on quality care, operational efficiency, and market understanding has positioned it as a key player in Eastern India’s healthcare sector, poised for continued growth and expansion
